EDP Biotech one of 13 labs listed on FDA’s serology testing sites
Knoxville-based EDP Biotech Corporation is one of 13 entities currently listed on the U.S. Food and Drug Administration’s website as a commercial testing lab and manufacturer of COVID-19 serology (antibody) tests. (NOTE: The company is listed in the answer to question 6 – “What laboratories and manufacturers are offering tests for COVID-19?”)
“EDP Biotech’s mission has always been to develop and commercialize cost effective blood tests that detect disease early,” said Eric Mayer, Chief Executive Officer. “While our top priority remains ColoPlex™ multiplex blood test for colorectal cancer and polyp detection, we recognize the high demand and supply shortage for serology testing in the United States. Serology testing for antibodies in the general population will be critical as the economy comes back to life and people return to work. This near-term opportunity allows EDP to begin generating revenue through blood testing (we already have our first customer and PO) and may lead to the use of ColoPlex™ early adoption in the U.S. as a lab-developed-test (LDT).”
